---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-325987"
form_type: "8-K"
ticker: "AMWL"
cik: "0001393584"
company_name: "American Well Corp"
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T09:48:15.075693+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Amwell Q3 revenue $62.2M, net loss improves to $50.9M; guides 2021 revenue lower, EBITDA higher

## Summary
- Revenue $62.2M vs $62.6M YoY; subscription revenue $26.7M (+3.5%), visit revenue $30.0M (+5.3%).
- Gross margin 43.5% vs 32.7% YoY; net loss ($50.9M) vs ($64.6M); Adj. EBITDA loss ($31.5M) vs ($26.2M).
- Total visits ~1.4M (up from 1.3M Q2); active providers ~80,000 (vs 71,000 Q2, 62,000 YoY).
- Narrows 2021 revenue guidance to $246-253M from $252-262M; lowers EBITDA loss guidance to ($143)-($136)M from ($154)-($146)M.
- Converge platform development on track; added Conversa Health and SilverCloud Health capabilities.

## SEC filing metadata
- accession: 0001193125-21-325987
- form_type: 8-K
- ticker: AMWL
- cik: 0001393584
- company_name: American Well Corp
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393584/000119312521325987/0001193125-21-325987-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393584/000119312521325987/d243099d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-325987
- JSON: https://secwatch.observer/filing/0001193125-21-325987.json
- Plain text: https://secwatch.observer/filing/0001193125-21-325987.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.